Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Alnylam, Eisai, Elevar, Glenmark, Hutchmed, Johnson & Johnson, Novartis, Pharmaessentia, Pint, Secretome, Telix.